iptacopan
EHA21: Novartis trumpets iptacopan as oral alternative to antibodies in PNH
Phil Taylor
Alexion, complement therapeutics, EHA 2021, Haematology, iptacopan, Novartis, rare disease, Soliris, Ultomiris
0 Comment
X
EHA21: Novartis trumpets iptacopan as oral alternative to antibodies in PNH
https://pharmaphorum.com/news/eha21-novartis-trumpets-iptacopan-as-oral-alternative-to-antibodies-in-pnh/